Inozyme Pharma

YTD

ALL

Why Robinhood?

You can watch Inozyme Pharma and buy or sell other stocks, ETFs, and their options commission-free!

About INZY

Inozyme Pharma, Inc. is a clinical-stage rare disease biopharmaceutical company. It engages in the business of developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton.

CEO

Doug Treco Treco, PhD

CEODoug Treco Treco, PhD

Employees

Employees67

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

Employees67

INZY Key Statistics

Market cap

257.88M

Market cap257.88M

Price-Earnings ratio

-2.38

Price-Earnings ratio-2.38

Dividend yield

—

Dividend yield—

Average volume

712.81K

Average volume712.81K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$6.24

52 Week high$6.24

52 Week low

$0.721

52 Week low$0.721

People also own

Based on the portfolios of people who own INZY. This list is generated using Robinhood data, and it’s not a recommendation.